Cheng J, Jackson M
J Physiol. 2024; .
PMID: 39141801
PMC: 11825891.
DOI: 10.1113/JP286175.
Acreman S, Zhang Q
Chronic Dis Transl Med. 2022; 8(1):7-18.
PMID: 35620162
PMC: 9128566.
DOI: 10.1016/j.cdtm.2021.06.001.
Cappellani D, Urbani C, Sardella C, Scattina I, Marconcini G, Lupi I
Endocrinol Diabetes Metab. 2019; 2(1):e00033.
PMID: 30815570
PMC: 6354758.
DOI: 10.1002/edm2.33.
Gonzalez-Mariscal I, Montoro R, Doyle M, Liu Q, Rouse M, OConnell J
Diabetologia. 2018; 61(6):1470-1483.
PMID: 29497784
PMC: 6201315.
DOI: 10.1007/s00125-018-4576-4.
Morita A, Ouchi M, Terada M, Kon H, Kishimoto S, Satoh K
Exp Anim. 2017; 67(1):15-22.
PMID: 28757517
PMC: 5814310.
DOI: 10.1538/expanim.17-0059.
Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients.
Christiansen Arlien-Soborg M, Trolle C, Alvarson E, Baek A, Dal J, Jorgensen J
Endocrine. 2017; 56(3):589-594.
PMID: 28260207
DOI: 10.1007/s12020-017-1258-9.
Inactivating the permanent neonatal diabetes gene Mnx1 switches insulin-producing β-cells to a δ-like fate and reveals a facultative proliferative capacity in aged β-cells.
Pan F, Brissova M, Powers A, Pfaff S, Wright C
Development. 2015; 142(21):3637-48.
PMID: 26534984
PMC: 4647212.
DOI: 10.1242/dev.126011.
Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.
Helseth R, Carlsen S, Bollerslev J, Svartberg J, Oksnes M, Skeie S
Endocrine. 2015; 51(2):298-307.
PMID: 26179177
DOI: 10.1007/s12020-015-0679-6.
Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.
Durham T, Toth J, Klimkowski V, Cao J, Siesky A, Alexander-Chacko J
J Biol Chem. 2015; 290(33):20044-59.
PMID: 26085101
PMC: 4536412.
DOI: 10.1074/jbc.M115.638205.
Assessment of re-aggregated human pancreatic islets for secondary drug screening.
Ramachandran K, Peng X, Bokvist K, Stehno-Bittel L
Br J Pharmacol. 2014; 171(12):3010-22.
PMID: 24641508
PMC: 4055202.
DOI: 10.1111/bph.12622.
An electroencephalographic investigation of short-term effects of three hypothalamic hormones (TRH, LH/FSH-RH, GH-RIH) in normal subjects.
Ashton H, Millman J, Telford R, Thompson J, Davies T, Hall R
Br J Clin Pharmacol. 2012; 3(4):523-31.
PMID: 22216490
PMC: 1428921.
DOI: 10.1111/j.1365-2125.1976.tb04871.x.
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study.
Giordano C, Ciresi A, Calogero Amato M, Pivonello R, Auriemma R, Grasso L
Pituitary. 2011; 15(4):539-51.
PMID: 22116639
DOI: 10.1007/s11102-011-0365-5.
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
de Glisezinski I, Larrouy D, Bajzova M, Koppo K, Polak J, Berlan M
J Physiol. 2009; 587(Pt 13):3393-404.
PMID: 19417097
PMC: 2727046.
DOI: 10.1113/jphysiol.2009.168906.
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
de Heer J, Rasmussen C, Coy D, Holst J
Diabetologia. 2008; 51(12):2263-70.
PMID: 18795252
DOI: 10.1007/s00125-008-1149-y.
Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
Lheureux P, Zahir S, Penaloza A, Gris M
Crit Care. 2005; 9(6):543-9.
PMID: 16356235
PMC: 1414034.
DOI: 10.1186/cc3807.
Somatostatin-induced paradoxical increase in intracellular Ca2+ concentration and insulin release in the presence of arginine vasopressin in clonal HIT-T15 beta-cells.
Cheng H, Yibchok-anun S, Park S, Hsu W
Biochem J. 2002; 364(Pt 1):33-9.
PMID: 11988073
PMC: 1222542.
DOI: 10.1042/bj3640033.
The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.
Beltrutti D, Moessinger S, Varrassi G
Curr Rev Pain. 2000; 4(1):82-90.
PMID: 10998719
DOI: 10.1007/s11916-000-0013-7.
Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.
Hori N, Okanoue T, Sawa Y, Mori T, Kashima K
Gastroenterol Jpn. 1993; 28(2):276-83.
PMID: 8486215
DOI: 10.1007/BF02779231.
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.
Aynsley-Green A, Polak J, Bloom S, GOUGH M, Keeling J, Ashcroft S
Arch Dis Child. 1981; 56(7):496-508.
PMID: 7023389
PMC: 1627357.
DOI: 10.1136/adc.56.7.496.
The milieu interieur and the islets of Langerhans.
Unger R
Diabetologia. 1981; 20(1):1-11.
PMID: 7009282
DOI: 10.1007/BF00253809.
